EEG Findings in Diffuse Lewy Body Disease and Parkinson ́S Disease with Dementia
نویسنده
چکیده
Objectives: Electroencephalography can still reveal a variety of focal abnormalities in different neurological diseases. EEG could represent an easy and economical tool to differentiate parkinsonisms when compare to neuroradiological studies. We want to report the EEG findings in a serie of diffuse lewy body disease and demented Parkinson ́s disease patients of our unit of movement disorders, in a prospective and open label study. Methods: 30 consecutive subjects were enrolled, 10 patients with criteria for diffuse lewy body disease, 10 patients with criteria for Parkinson’s disease (demented) and 10 normal subjects. The MMSE, the GDS/FAST staging scale, the UPDRS and the Schwab and England scales and NPI-Q scale were administered. A 36-channel video-QEEG recording and Spectral EEG analysis were determined in patients and subjects. Results: Diffuse lewy body disease patients showed a mean of occipital frequency of 7.7 ± 0.3 Hz (P: 0.04), 70% of them showed temporal lobe amplitude’s asymmetries (P: 0.04) and 90% showed a Frontal Intermittent Delta Activity (P: 0.02). Parkinson’s disease patients showed a mean of occipital frequency of 8.8 ± 0.8 Hz, 20% of them showed temporal lobe asymmetries and 10% showed Frontal Intermittent Delta Activity. Frontal Intermittent Delta Activity and temporal lobe amplitude’s asymmetries in Diffuse lewy body disease patients were statistically significant compared to the normal subjects, while the Parkinson’s disease patients showed no statistical differences from normal subjects. Conclusions: Electroencephalographic findings in Diffuse Lewy Body Disease patients could represent an electrophysiological marker that might aid in distinguishing Diffuse Lewy body disease patients from Parkinson’s disease patients, further studies are needed to validate our results
منابع مشابه
Rapidly progressive diffuse Lewy body disease.
BACKGROUND Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. OBJECTIVE To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. METHODS Review clinical records and pathological ...
متن کاملUptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The heart-tomediastinum ratio (H/M) in PD and DLB is significantly lower than that in Parkinson’s plus syndromes and Alzheimer’s disease. Although this ra...
متن کاملDiffuse Lewy body disease: clinical features in 15 cases.
Fifteen cases of diffuse Lewy body disease were diagnosed on pathological grounds during a single year in one health district. The range and frequency of clinical features contrast strikingly with previous reports. The majority of cases presented with classical levodopa-responsive Parkinson's disease either alone (6 cases) or with mild cognitive impairment (3 cases); the remaining 6 cases prese...
متن کاملDiffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.
OBJECTIVE To further elucidate the relation between diffuse Lewy body disease and Parkinson's disease. METHODS AND RESULTS The clinical features of nine cases of pure diffuse Lewy body disease without pathological evidence of coexisting Alzheimer's neuritic pathology were reported. All patients were aged less than 70 years at onset (mean 62 years). Five patients presented with clinical featur...
متن کاملDiffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities...
متن کامل